Las mujeres embarazadas o que planean quedar embarazadas deben suspender tirzepatide al menos 1 mes antes de la concepcin planificada, ya que no se ha establecido su seguridad durante el embarazo
Past and recent medical history, comorbidities, presumed VPA ingested doses, co-ingested compounds, clinical presentation, laboratory parameters, toxicological analysis, management, complications and outcome were recorded
Clinical trials have shown that Tirzepatide consistently outperforms existing medications, making it a game-changing therapy for patients and providers alike
treatment ships only if a provider finds it clinically appropriate
1 They are also implicated in the pathophysiology of diseases such as T2DM, in which inflammation, high adiposity, dyslipidemia, and the formation of harmful lipid-derived metabolites contribute to insulin resistance